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Abstract Centralisation of services such as cardiology, cardiac surgery, and intensive care in many parts of the
world has resulted in the need to safely transport children with critical cardiac disease from local hospitals to
specialist centres for diagnostic, surgical, and/or critical care intervention. The transport of this cohort of children,
whether locally or internationally, can present speciﬁc clinical and logistical challenges. An international group
of clinicians with expertise in cardiac care and critical care transport worked together to summarise current
clinical practice relating to key areas of transport. This expert review covers the transport of the child with critical
cardiac disease in terms of referral triage and advice, enabling optimal management of locally available resources,
clinical stabilisation before transport, international air transport, transport considerations in low- and middle-
income countries, and the transport of children with speciﬁc cardiac conditions. As specialist services are
centralised to fewer large centres, the need for safe and timely inter-hospital transport of children with critical
cardiac disease is only expected to rise in the future. The key principles outlined in this review will be helpful for
practitioners in global settings who are, or might be, involved in transporting children between hospitals.
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Background
Owing to the centralisation of services such as cardio-
logy, cardiac surgery, and intensive care in many
parts of the world, children with critical cardiac
disease presenting to local hospitals frequently
require stabilisation and safe transport to specialist
centres for diagnostic, surgical, and/or critical care
intervention.1–3 The inter-hospital transport of this
group of patients can present particular clinical and
logistical challenges.4 Children with critical cardiac
disease often have greater severity of illness and
require signiﬁcant stabilisation before transport;
their complex circulatory physiology, particularly in
children who have had multiple previous cardiac
interventions, is more likely to be affected by events
common during transport such as acceleration–
deceleration and changes in ventilation; the potential
for rapid physiological deterioration means that close
monitoring by experienced staff is a crucial con-
sideration; and the absence of a clear cardiac diagnosis
in many cases complicates clinical decision-making
and the selection of an appropriate destination unit.
Inter-hospital transport of children with critical
cardiac disease should usually be undertaken by a
team with specialist training and experience in the
areas of cardiac critical care and transport.5
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In this expert review, we will cover aspects related
to the transport of critically ill children with cardiac
disease such as referral triage and advice, transport
decision-making, aeromedical and international
transport, and the management of speciﬁc cardiac
conditions during transport.
Referral triage and advice
The main purpose of triage before transport is to assess
the clinical condition of the patient, including whe-
ther a cardiac diagnosis is conﬁrmed and how critically
ill the patient is; assess the local capabilities and
resources available – for example, availability of staff to
perform critical interventions and diagnostic tests, and
whether telemedicine is available and appropriate; and
provide recommendations to stabilise the patient
while waiting for a transport team to arrive.6 Advice
given should be tailored to the clinical scenario and the
capabilities of the referring centre. At the same time,
there must be a recognition that some urgent inter-
ventions cannot wait until the arrival of the transport
team. Empowering local staff to use available resources
effectively is an important part of the triage process.
Clinical assessment and advice
Clinical assessment and advice provision should be
completed rapidly and, if necessary, in consultation
with relevant specialists (cardiologist, cardiac inten-
sivist). A systematic and structured approach is
important. Key points relating to clinical assessment
and advice are shown in Table 1.
Assessment and optimisation of local resources
Children with critical cardiac disease are often
severely ill and require the most experienced staff
available to care for them. A team-based approach
should be adopted.7 Staff with airway skills and those
with knowledge related to the cardiac condition
should be available. While in some settings this
might be the cardiac intensive care team, in many
settings members of anaesthetic and paediatric teams
should be present during stabilisation to complement
each other’s skills and knowledge. Neonatologists
should be involved in acute care of neonates where
possible. In settings in which local staff resources are
limited, the most experienced person (or people) with
advanced life support skills should lead the clinical team.
The unavailability of equipment and trained
operators may limit the capability of local staff. Staff
with even basic echocardiographic skills are likely to
be unavailable in many settings, highlighting the
importance of clinical assessment in cardiac disease.
Anaesthetic staff may be unfamiliar with intubation
in children or lack advanced airway equipment –
supraglottic airway devices can provide a safe alter-
native option to manage the airway and may provide
effective ventilation in such cases.8 Intraosseous
access can serve as an effective alternative to central
venous access even when staff have limited experience
in obtaining venous access.9
Ongoing advice from the remote specialist centre
(or transport team) is important to support the local
hospital during stabilisation. Traditional telephone-
based approaches may be replaced by video consulta-
tion models in the future.10 Advances in technology
mean that even mobile phones can be used for this
purpose. Although the existing evidence base is weak,
adoption of telemedicine has been shown to improve




The general principles related to the transport of the
child with critical cardiac disease are as follows:
∙ As interventions while travelling in the ambulance or
aircraft can be technically difﬁcult and associated with
a higher risk of complications, stabilisation is best
performed at the referring hospital before transport.
∙ Achieving physiological stability may not be possible
in some scenarios where a deﬁnitive intervention can
only be performed at the specialist centre. Typical
examples are transposition of the great arteries
with poor mixing – where an urgent balloon atrial
septostomy is required – and obstructed total
anomalous pulmonary venous return – where
emergency surgery is required. Prior awareness of
these conditions should highlight to the transport
team that once life-saving interventions such as
intubation and ventilation have been performed, the
child should be rapidly transferred to the specialist
centre. When there is no clear diagnosis, failure to
respond to key interventions as expected – for
example, refractory severe hypoxia despite adequate
ventilation – should warn the transport team that a
“time-critical” transfer is required. In rare circum-
stances in which “time-critical” transport involves
very long distances, it may be necessary to stabilise
the child before transport by placing them on
extracorporeal life support for the transport.12
Transport logistics
Type of team. The risk of complications during
transport and a strong evidence-base supporting the
use of specialist retrieval teams to perform critical
care transports suggest that most children with
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cardiac disease should be transported by specialist
transport teams.1,5 Specialist teams are also more likely
to maintain up-to-date skills by regular exposure in
clinical practice and during simulated training. Rarely,
it may be necessary to transport patients using local
staff, mainly owing to lack of timely availability
of a specialist team or for time-critical transfers; in
these cases, staff with the most experience in managing
patient deterioration during transport should
accompany the patient. These teams may sometimes
be local adult or neonatal critical care transport teams.
Transport equipment. The risk of complications
during transport means that children with cardiac
disease being transported to a specialist centre should
undergo multi-parameter monitoring – continuous
echocardiogram and heart rate, oxygen saturations,
non-invasive or invasive blood pressure measurement,
temperature, and end-tidal CO2 for ventilated
patients – using portable, battery-operated
monitors.13 The team should have access to a
portable mechanical ventilator that is battery-
operated, or pneumatically driven, and can ventilate
Table 1. Key points relating to clinical assessment and advice during triage for transport.
Domains Clinical assessment Advice
Airway Presence of stridor and its nature – inspiratory: croup,
subglottic stenosis; biphasic: tracheal/bronchial obstruction
due to tumour, double aortic arch, or absent pulmonary valve
syndrome
Presence of stertor – functional airway obstruction due to poor
conscious level
Presence of, or suspected, genetic syndromes with
dysmorphism such as Trisomy 21, Pierre Robin sequence, Di
George syndrome
Previous anaesthetic history of difﬁcult intubation
Last oral/enteral feed
Anticipate difﬁculty with intubation
Seek support from the most senior airway specialist available
locally (anaesthetist, neonatologist, ENT specialist)
Ensure naso/oro-gastric tube in place and gastric contents
emptied
Breathing Signs of respiratory distress (tachypnoea, grunting, recessions)
Extent of hypoxia and hypercarbia
Presence of wheeze and/or crackles on auscultation
Signs of lung disease on chest X-ray (consolidation, collapse,
pneumothorax, effusions)
Oxygen supplementation to avoid hypoxia. If cardiac disease is
not conﬁrmed, it is safe to aim for SpO2 target 80–85%
If available, high-ﬂow nasal cannula therapy or CPAP
(including bubble CPAP)
Intubation and ventilation if severe respiratory failure
Circulation Family history of neonatal deaths, rhythm disturbances, or
CHD
Maternal history of rubella, drug use, or diabetes
History of feeding and growth
Rapidity of onset of symptoms
Clinical signs of shock (tachycardia, poor volume pulses, poor
perfusion), cyanosis, ﬁnger clubbing, femoral pulse volume,
4-limb blood pressure, heart murmur, pre- and post-ductal
pulse oximetry and any gradient, hepatomegaly
Chest X-ray signs of cardiomegaly, lung vascular markings
(oligaemia versus plethoric lungs), vertebral or rib anomalies,
classic ﬁndings such as boot-shaped heart or snowman
appearance
Early consideration of prostaglandin infusion to maintain
ductal patency in suspected CHD
Timely reversal of shock with careful ﬂuid bolus therapy, in
small aliquots of 5–10ml/kg, and inotropic agents such as
adrenaline, dopamine, and/or milrinone
Neurology Level of consciousness – coma may indicate profound
circulatory collapse or prolonged severe hypoxia or, in older
children, a stroke
History of seizures or abnormal movements, which may be seen
following cardiopulmonary bypass surgery or associated with
multisystem genetic diagnoses such as Trisomy 21 or tuberous
sclerosis
History of syncope
Intubation to protect airway if severe coma, responding only to
pain, or loss of cough/gag reﬂexes
Anticonvulsant therapy
Early cranial imaging such as ultrasound and CT scan to rule
out bleeding/mass
Continuous ECG monitoring to identify rhythm abnormalities
Metabolic Blood sugar level
Serum calcium, persistently low in hypoparathyroidism seen
with Di George syndrome, magnesium, potassium and
sodium, low with chronic diuretic use,
Renal function, hepatic function tests




Presence of two large-bore intravenous cannulae
Previous history of central venous access or thrombosis
Ultrasound-guided venous access, if available
External jugular vein is often patent even in collapsed infants
Early intraosseous access in shocked children – upper end of
tibia, lower end of femur, and upper end of humerus
CPAP= continuous positive airway pressure; ENT= ear, nose and throat.
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patients of various ages – newborn through
adolescent. A deﬁbrillator that can be operated in
manual mode – ideally combined with transthoracic
pacing capabilities – is recommended for most
patients. A standardised bag with transport supplies
to manage the airway, breathing, and circulation
should be available.14
Aeromedical transport. The primary motivation for
air transport is to achieve a speedy patient transfer to
the specialist centre. However, several factors, such as
how quickly a helicopter or ﬁxed-wing aircraft is
available, how far the landing sites are from both
hospitals, and weather considerations, affect any
expected time-savings from aeromedical transport.
On the other hand, air transport carries small but
signiﬁcant risks to patients and staff. Therefore, the
decision to ﬂy must be made after careful consideration
of the risks and the expected beneﬁts in each case.
The main patient risks from aeromedical transport
relate to physiological changes associated with alti-
tude and the G-forces associated with ﬂight.15,16
With increasing altitude, gas expansion can pose a
signiﬁcant problem when it is trapped in a body
cavity – for example, pneumothorax, pneumo-
peritoneum, gastric cavity – or contained within
medical equipment – for example, endotracheal tube
cuff and urinary catheter cuff. Attention should be
paid to draining trapped gases before ﬂying – for
example, nasogastric tube on free drainage and chest
drain inserted – and to deﬂate/inﬂate cuffs during
take-off and landing. Hypoxia from ﬂying at an
altitude can be dangerous in cardiac disease with pre-
existent cyanosis – supplemental oxygen may be
required. Take-off and landing are particularly dan-
gerous in shock states because of G-forces; therefore,
head down or feet up during take-off to prevent
pooling of blood in the lower extremities, or the use
of ﬂuid boluses to increase preload, may be needed.
Noise and vibration associated with helicopter
transport, and the cramped working environment,
impose an additional burden on the staff caring for a
critically ill child. Ear plugs for children and head-
sets/helmets for staff should be used to minimise
prolonged exposure to noise.
International transports. The main feature of
international transports is the long distance involved.
For high acuity patients, a dedicated air ambulance
may be the most effective means of transport,
providing adequate physical space and access to
oxygen and/or power; however, in most other cases, a
commercial aircraft is preferred owing to speed and the
advantage of avoiding multiple refuelling stops.
Military aircrafts are also frequently used for
international transports. Primary considerations related
to such transports are staff numbers and expertise – for
example, for long transports stretching over several
hours, more than two members of staff may be required
to avoid fatigue, and where patient deterioration is
expected, staff should be able to provide critical
care interventions in ﬂight – and equipment – for
example, battery-powered with additional batteries
available, ventilators with a compressor-driven turbine
to avoid the need for heavy air cylinders and able to
function using low-ﬂow oxygen, and ability of
equipment to be safely secured in the aircraft.17
Transports in resource-limited settings. The limited
healthcare infrastructure in low- and middle-income
countries poses several different challenges relating to
the transport of children with critical cardiac disease.18
Many low- and middle-income countries’ settings do
not have established services for cardiology, cardiac
surgery, or paediatric intensive care. As antenatal
echocardiography is unavailable, the majority of
infants with cardiac disease are born in village health
outposts and smaller town health centres/hospitals or
at home, and are diagnosed in the postnatal period or
later. Vital medications such as prostaglandin may be
unavailable, and there is a scarcity of dedicated staff
trained in transport. Depending on the complexity of
the lesion and the resources available locally, patients
may be managed locally awaiting surgical input, by
visiting cardiac charity missions such as Chain of
Hope, United Kingdom, or International Children’s
Heart Foundation, United States of America;
transported to a larger regional centre where
corrective or palliative surgery may be possible; or
require international transport to a high-income
country for surgical intervention.
The key considerations for transport are the clinical
status of the patient, the end point of management,
which teams need to be involved in the discussions/
management plan, the distance required to travel, who
will accompany the patient on the transfer, what
resources are available for the transfer – equipment,
mode, and vehicle used – and the discussions with the
family/carers/patient. It may be necessary to adapt
existing adult ambulances to secure the child using a
bassinet, kangaroo pouch, or car seats (Fig 1). There
must be a clear plan to ensure continuous monitoring,
whether this is direct visualisation or use of limited
resources, for example, oximetry. The need for venous
access should be assessed, and a decision should be
made regarding whether the patient should be fed
during the transfer. The practicalities of storage of
medications, labelling of drugs, and delivery of intra-
venous medications under clean conditions should be
considered. For long-distance international transports
in commercial aircraft, a “grab bag” (limited, essential
equipment) should be readily available, and secure
venous access should be in place to deliver life-saving
medications such as prostaglandin. Most commercial
airlines would not be able to deliver oxygen at take-off
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and landing, and it may be necessary to carry portable
oxygen cylinders or oxygen concentrators. Secure
ﬁxation of equipment to avoid dislodgement during
turbulence is an important safety consideration.
International volunteer transport teams should be
aware of the medicolegal ramiﬁcations and ensure
that their medical protection unions will cover such
activity, keep detailed medical records, and obtain
consent from the parents/carers and referring team
before undertaking these transfers.
Clinical management during transport
Key points related to clinical management by the
transport team are summarised in Table 2.
Management of speciﬁc cardiac conditions during
transport
Speciﬁc cardiac conditions are grouped into six
clinically relevant categories and key points relating
to their management during transport are
summarised below.
Antenatally diagnosed CHD. Prostaglandin
infusion at small doses (5–10 ng/kg/minute) should
be used to maintain ductal patency during the
transport of the baby to the specialist centre.
Intubation is not usually routinely required if the
dose does not exceed 15 ng/kg/minute.19,20
The “blue neonate”. If the diagnosis is in doubt, a
hyperoxia test – SpO2 or PaO2 response to short-term
administration of 100% oxygen – may be helpful to
differentiate lung disease from cardiac disease. In
most cases of cyanosis where a cardiac cause is
suspected, ductal patency should be maintained
using a prostaglandin infusion. Intubation is usually
required when the dose of prostaglandin infusion is
greater than 15 ng/kg/minute owing to the risk of
apnoea.
D-transposition of great arteries. High doses of
prostaglandin may be required to reopen a closed
duct (10–20 ng/kg/minute, 20–50 ng/kg/minute in
some cases). Failure to improve oxygen saturations
with a prostaglandin infusion, particularly in a
neonate with cyanosis and plethoric lungs, indicates
that an urgent balloon atrial septostomy is required,
usually under specialist cardiology care. Time to
septostomy can be an important factor in the survival
and neurodevelopmental outcomes of newborns with
d-transposition of the great arteries; therefore, rapid
transport is essential. Fluid administration and
adrenaline (epinephrine) infusions may be useful
but should not delay transport.
Figure 1.
Transporting a neonate with transposition of great arteries in a
low-middle income country from hospital to airport for a commercial
ﬂight. Note the use of an adult ambulance and the adaptation of a
bassinet to secure the child.
Table 2. Key messages for the clinical assessment and stabilisation of children with critical cardiac disease.
Domains Key points for assessment and stabilisation
Airway Reposition airway to maintain patency – roll under the neck, prone position in Pierre Robin syndrome
Endotracheal intubation may be required for transport. Use an intubation checklist to provide a safety net, ensuring that the right
people, the right equipment, and the right plans are in place
Have specialist equipment, such as laryngeal mask airway, gum elastic bougie, and video-assisted laryngoscope, available in case of
anticipated difﬁcult airway
Use cardiostable induction agents such as ketamine or fentanyl
Use a cuffed endotracheal tube, from 3.5mm size upwards
Breathing Use supplemental oxygen to target SpO2 of 75–85% to avoid pulmonary over-circulation
Use non-invasive respiratory support, such as high-ﬂow nasal cannula and CPAP, for moderate respiratory distress
Provide invasive ventilation if required, with adequate PEEP to support myocardial function and manage pulmonary oedema
Circulation As most cardiac defects in the neonatal period – <28 days of age – are likely to have a duct-dependent circulation, either
pulmonary or systemic, start prostaglandin (PG) infusion to maintain ductal patency in all suspected cases of CHD
Limited ﬂuid resuscitation using 5–10ml/kg bolus
Use inotropic support using adrenaline (0–0.5mcg/kg/min), dopamine (5–10mcg/kg/min), and/or milrinone (0.3–0.7mcg/kg/min)
infusions
Inotropes can be delivered via peripheral veins if required, although central venous or intraosseous access is safer
CPAP= continuous positive airway pressure; ECG= echocardiogram; PEEP= positive end-expiratory pressure.
S44 Cardiology in the Young: Volume 27 Supplement 6 2017
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S1047951117002608
Downloaded from https://www.cambridge.org/core. UCL, Institute of Education, on 24 Oct 2018 at 10:57:20, subject to the Cambridge Core terms of use, available at
Obstructed total anomalous pulmonary venous
return. Urgent transfer for surgery may be required
if profound cyanosis unresponsive to conventional
therapies – prostaglandin infusion and ventilation –
suggests a diagnosis of total anomalous pulmonary
venous return. The presence of systemic hypoperfusion
with lactic acidosis makes the diagnosis of obstructed
very likely, but without echocardiography obstructed
total anomalous pulmonary venous return is difﬁcult
to distinguish from persistent pulmonary hypertension
of the newborn, and a short trial of inhaled nitric oxide
may be required. Lack of response should lead to
termination of the trial of inhaled nitric oxide to avoid
further pulmonary vasodilatation; prostaglandin
infusion may not always be helpful, but it should
always be started to assess response.
The “shocked” neonate. Septic shock and obstruction
to systemic cardiac output are the main differential
diagnoses to consider in the “shocked” neonate. In most
cases of neonatal shock where a cardiac cause is
suspected, ductal patency should be maintained using
a prostaglandin infusion. Intubation is usually required
when the dose of prostaglandin infusion is >15ng/kg/
minute or evidence of systemic hypoperfusion is
present. Pulmonary over-circulation should be
prevented by maintaining a pulmonary to systemic
perfusion (Qp:Qs) ratio of 1:1, usually achieved by
adjusting the FiO2 to target oxygen saturations of
75–85% and normalising the pH and pCO2. Severe
acidosis can be treated with sodium bicarbonate to
improve myocardial function; intravenous inotropic
support can be provided by dopamine and/or adrenaline
infusions; and milrinone may be useful to provide
lusitropy, inotropy, and to reduce afterload. Blood
transfusion to optimise oxygen-carrying capacity and
measures to decrease oxygen consumption, such as
sedation, muscle relaxation, and avoidance of
hyperthermia, should also be considered. In
hypoplastic left heart syndrome with a restrictive atrial
connection, shock does not respond to conventional
management, indicating a speciﬁc situation in which a
“time-critical” transfer to the specialist centre will be
required.
The “blue” infant or child. Cyanosis may be a
presenting feature in a child in the setting of
undiagnosed cyanotic heart disease, repaired heart
defects, or from pulmonary pathology. The
management of spells during transport in cases of
tetralogy of Fallot involves the administration of
100% oxygen, intravenous morphine, β-blockers
such as propranolol, ﬂuid bolus to increase preload,
and increasing the systemic vascular resistance by
vasoconstrictors such as phenylephrine, metaraminol,
or noradrenaline infusion. Intubation and ventilation
may be required when response to conventional
treatment is inadequate and/or if repeated spells
occur in a short period of time, with associated
metabolic acidosis. In cases of blocked systemic-
pulmonary shunt, ﬂuid volume administration and
intravenous heparin are indicated, with rapid transfer
to the specialist centre for urgent intervention.
The infant or child in heart failure. Main treatment
principles include oxygen therapy, judicious ﬂuid
management to avoid ﬂuid overload, diuretic
therapy, and support for the failing myocardium.
Myocardial support can be provided by positive
pressure ventilation, either using non-invasive
ventilation or intubation and ventilation. Support
for the failing myocardium can be provided by the
use of inotrope infusions (adrenaline, dopamine,
dobutamine, or milrinone).
The child with an abnormal heart rhythm. Minimum
monitoring during transport should include
continuous electrocardiogram, pulse oximetry,
regular blood pressure, and respiratory rate, and
deﬁbrillation pads should be in place on the child
during the transport in preparation for intervention.
A deﬁbrillator capable of delivering synchronous and
asynchronous direct current (DC) shocks, as well as
transthoracic pacing, should be readily available.
Supraventricular tachycardia. If adenosine fails to
restore sinus rhythm and shock persists, or if intrave-
nous access is not available, synchronised cardioversion
(1 J/kg) should be administered. Cardioversion will
usually require an infant’s airway to be stabilised
by intubation ﬁrst, although older children can be
managed with sedation alone – using midazolam or
ketamine. An infusion of amiodarone, at a loading
dose of 25 μg /kg/minute for 4 hours, and then
5–10 μg/kg/minute, should be considered in refractory
cases.
Ventricular tachycardia. Haemodynamic instability
should be managed with DC cardioversion (1–2 J/kg)
once the airway and breathing have been stabilised.
Polymorphic ventricular tachycardia – torsades de
pointes – can be treated with intravenous magnesium
sulphate (25mg/kg).
Complete heart block. Stabilisation and initiation of
agents such as isoprenaline or adrenaline infusions
may be used to increase the heart rate. In refractory
complete heart block, transcutaneous pacing may be
required during transport.
Conclusion
With increasing focus on the centralisation of spe-
cialist services in fewer centres, or lack of specialist
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services in many parts of the world, the need for
inter-hospital transport of children with critical
cardiac disease is only likely to rise. The key princi-
ples of safe transport include robust triage and
advice provision, clinical stabilisation before trans-





This research received no speciﬁc grant from any




1. Ramnarayan P, Thiru K, Parslow RC, et al. Effect of specialist
retrieval teams on outcomes in children admitted to paediatric
intensive care units in England and Wales: a retrospective
cohort study. Lancet 2010; 376: 698–704.
2. NHS England. New congenital heart disease review: ﬁnal report.
London, 2015.
3. Lundstrom NR, Berggren H, Bjorkhem G, et al. Centralization
of pediatric heart surgery in Sweden. Pediatr Cardiol 2000; 21:
353–357.
4. Orr RA, Kuch BA. Triage and Transport of Infants and Children
with Cardiac Disease. In: Munoz R, (ed.). Critical Care of
Children With Heart Disease: Basic Medical and Surgical
Concepts. Springer-Verlag, London, 2010: 13–21.
5. Orr RA, Felmet KA, Han Y, et al. Pediatric specialized transport
teams are associated with improved outcomes. Pediatrics 2009;
124: 40–48.
6. Warren J, Fromm RE Jr, Orr RA, et al. Guidelines for the inter-
and intrahospital transport of critically ill patients. Crit Care Med
2004; 32: 256–262.
7. Department of Health. The acutely or critically sick or injured child
in the district general hospital: a team response. London, 2006.
8. Ostermayer DG, Gausche-Hill M. Supraglottic airways: the history
and current state of prehospital airway adjuncts. Prehosp Emerg
Care 2014; 18: 106–115.
9. Fiorito BA, Mirza F, Doran TM, et al. Intraosseous access in the
setting of pediatric critical care transport. Pediatr Crit Care Med
2005; 6: 50–53.
10. Satou GM, Rheuban K, Alverson D, et al. Telemedicine in pedia-
tric cardiology: a scientiﬁc statement from the American Heart
Association. Circulation 2017; 135: e648–e678.
11. Dayal P, Hojman NM, Kissee JL, et al. Impact of telemedicine on
severity of illness and outcomes among children transferred from
referring emergency departments to a children’s hospital PICU.
Pediatr Crit Care Med 2016; 17: 516–521.
12. Perez A, Butt WW, Millar KJ, et al. Long-distance transport of
critically ill children on extracorporeal life support in Australia.
Crit Care Resusc 2008; 10: 34.
13. Sarfatti A, Ramnarayan P. Transport of the critically ill child.
Paediatr Child Health, 27: 222–228.
14. Dawes J, Ramnarayan P, Lutman D. Stabilisation and transport of
the critically ill child. J Intens Care Soc 2014; 15: 34–42.
15. Valente ME, Sherif JA, Azen CG, et al. Cerebral oxygenation and
acceleration in pediatric and neonatal interfacility transport. Air
Med J 2016; 35: 156–160.
16. Farmer JC. Respiratory issues in aeromedical patient transport.
Respir Care Clin N Am 1996; 2: 391–400.
17. Beninati W, Jones KD. Mechanical ventilation during long-range
air transport. Respir Care Clin N Am 2002; 8: 51–65.
18. Duke T. Transport of seriously ill children: a neglected global issue.
Intens Care Med 2003; 29: 1414–1416.
19. Meckler GD, Lowe C. To intubate or not to intubate? Transporting
infants on prostaglandin E1. Pediatrics 2009; 123: e25–e30.
20. Browning Carmo KA, Barr P, West M, et al. Transporting
newborn infants with suspected duct dependent congenital heart
disease on low-dose prostaglandin E1 without routine mechanical
ventilation. Arch Dis Child Fetal Neonatal Ed 2007; 92:
F117–F119.
S46 Cardiology in the Young: Volume 27 Supplement 6 2017
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S1047951117002608
Downloaded from https://www.cambridge.org/core. UCL, Institute of Education, on 24 Oct 2018 at 10:57:20, subject to the Cambridge Core terms of use, available at
